The hottest Neurotech Substack posts right now

And their main takeaways
Category
Top Science Topics
NEUROTECH FUTURES 119 implied HN points 15 Apr 24
  1. Neurotech developments in April 2024 include significant funding for startups like Syntropic, Neurava, and Seaport Therapeutics.
  2. Commercial advancements in neurotechnology involve companies like Synchron, NeuroOne, and Cognito Therapeutics launching new products and making significant progress in their fields.
  3. Regulatory updates show clearances for devices by FDA, submissions like ONWARD Medical's De Novo Application, and the importance of FDA approvals in the neurotech industry.
NEUROTECH FUTURES 119 implied HN points 29 Mar 24
  1. Neurotech experienced significant growth and activity in Q1 2024, with $400 million raised in private capital, over 20 FDA decisions, and various partnerships and initiatives.
  2. Recent developments in neurotechnology include increased focus on Brain-Computer Interface (BCI) news, new partnerships, and Neuroethics considerations worth exploring.
  3. The Neurotech industry continues to see advancements in funding, market recognition, regulatory clearances, and collaborations, indicating a growing interest and investment in neurotechnology.
NEUROTECH FUTURES 119 implied HN points 25 Mar 24
  1. Patient advocates are crucial in guiding advancements in brain-computer interface technology towards impacting those with physical impairments.
  2. Drawing parallels with established markets like Deep Brain Stimulation can offer insights into the future of BCI companies' commercial and regulatory pathways.
  3. Understanding the global landscape of BCI technology involves examining regulations, national interests, and technological advancements in different countries.
NEUROTECH FUTURES 99 implied HN points 29 Feb 24
  1. Neurotech is rapidly advancing with innovations like brain implants, non-invasive treatments, and brain-computer interfaces.
  2. Funding is flowing into neurotech startups for various applications like neuromodulation, brain stimulation, and remote disease monitoring.
  3. Regulatory clearance and FDA approvals are key developments, allowing new technologies to enter the market for improved brain health care.
NEUROTECH FUTURES 79 implied HN points 03 Feb 24
  1. January 2024 was a busy month for neurotech funding, with companies like Motif Neurotech, Cognito Therapeutics, and Rune Labs securing significant investments.
  2. Commercial headlines in neurotech highlighted important developments from companies like Synchron, Neuralink, BIOS Health, and Magstim demonstrating progress in the industry.
  3. Neuroethics and society discussions included announcements for conferences, grants, and events focusing on the ethical implications and societal impact of neurotechnology.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
NEUROTECH FUTURES 59 implied HN points 14 Feb 24
  1. Neurotech industry news: Companies like Elemind, Brain Scientific, Healium, and more are making advancements in neurotechnology with new products and FDA clearances.
  2. Industry analysis and activities: Discussions and events are happening around topics like investing in neurotech startups, brain scanning technology, and advancements in deep brain stimulation for Parkinson's disease.
  3. Community engagement: Aside from the serious industry news, there are fun and interesting neuroscience-related studies and activities for people to enjoy, such as research on penguin microsleep and a neuroscience poetry contest for kids.
NEUROTECH FUTURES 59 implied HN points 19 Jan 24
  1. Neurotech companies are focusing on new business models and innovation in care models, storytelling and fundraising, AI, data generation, and reputation-building.
  2. The 'killer app' for neurotech could be a reliable diagnostic test for Alzheimer's and investment in VR technology for mental health and wearables.
  3. Neurotech is impacting life sciences by advancing digital biomarkers for cognitive health, exploring treatments for Alzheimer's, and focusing on precision neurology and bioelectronics.
NEUROTECH FUTURES 19 implied HN points 15 Mar 24
  1. Neurotech industry saw significant fundraising, with companies like Phagenesis, Neurable, and Nalu Medical securing multimillion-dollar investments for various neurotech projects.
  2. The launch of the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC) marked a significant development in guiding Brain-Computer Interface technology into the future through collaborative efforts with foundations, startups, and regulatory bodies.
  3. Various industry news and regulatory updates highlighted advancements in neurotechnology, such as Sensory Stimulation for Alzheimer's, neuromodulation for long COVID by Parasym, and FDA breakthroughs for companies like SetPoint Medical and Empatica.
NEUROTECH FUTURES 19 implied HN points 20 Jan 24
  1. Neurotech commercial market segments are challenging to define accurately due to numerous reports and estimates about various topics like BCI, neuromodulation, productivity tech, diagnostics, imaging, monitoring, and AI.
  2. Important commercial market segments in neurotech include consumer wearables, clinical diagnostics & monitoring, clinical treatment & intervention, life sciences, and research & manufacturing.
  3. Market research in neurotech often focuses on technology rather than who is actually paying for and using the tech to help people, leading to a need for critical thinking about the real market landscape.
Asimov Press 83 implied HN points 13 Feb 23
  1. Biology is unique because it allows measuring designs in real experiments at massive scales.
  2. AI and machine learning are driving breakthroughs in biology including genome editing prediction and antimicrobial peptide discovery.
  3. Advancements in neurotech include brain-computer interface speed records and LED implants for vision stimulation.
GOOD INTERNET 13 implied HN points 28 Feb 24
  1. Advancements in brain-computer interface (BCI) technology have been rapidly evolving, such as enabling paralyzed individuals to walk, use their arms, feel sensations, and even restore speech with brain implants.
  2. Debates surrounding the ethics of brain interfaces are essential, with a need for broader public discourse on topics like neuro-rights and neuro-privacy as technology progresses.
  3. The potential for AI interpreting neural activity between individuals and the implications of direct digital 'telepathy' raise concerns about privacy, surveillance, and ethical boundaries with advancements in neurotechnology.
GOOD INTERNET 17 implied HN points 26 May 23
  1. Neuralink has received approval for human trials, showing progress in Brain-Computer-Interface technology.
  2. Advancements in AI are enabling the translation of human thoughts into language and aiding paralyzed individuals.
  3. Ethical concerns arise with BCI technology, including privacy issues and the potential for manipulation, highlighting the need for careful consideration and regulation.
NEUROTECH FUTURES 1 HN point 13 May 24
  1. Elemind, a neurotech startup, raised $12 million but displays red flags such as lack of product-market fit and a potential mismatch between its science and business teams.
  2. The company has made eyebrow-raising claims about its technology, including rapid results in sleep induction and other neurological benefits.
  3. Critical analysis is crucial in the neurotech industry to steer clear of potential scams and inflated promises.
Rough Diamonds 3 implied HN points 27 Jan 24
  1. EEGs measure brain activity by recording fluctuations in electrical signals.
  2. Different brain wave frequencies on EEGs correspond to different mental states like sleep, relaxation, alertness, and conscious perception.
  3. Consumer-grade EEG devices are noisier than clinical ones but can still provide useful insights into brain activity, especially for applications like monitoring drowsiness or stress.